Raman Pharma is a UK based MHRA and VMD Licensed Wholesaler supplying to the Human and Veterinary Market. We are a family run company ambitiously changing the face of the Pharmaceutical and Veterinary Market alike in order to serve the needs of our customers and their patients.
Our Philosophy and business are structured around the requirements of our customers and we are committed to giving them our upmost attention and care. We believe in delivering quality and value to our customers wherever they may be.
The Herbal Horse and Pet is a South African manufacturer of a very innovative range of supplements for horses, dogs and cats. Their philosophy of using a large number of different ingredients in small amounts mimics nature in that the healing effect of the ingredients is maximised while undesirable side-effects are minimised. These unique formulations, in conjunction with 21st century scientific research and techniques are what they call “cutting edge nature”.
They are manufactured in a GMP Compliant Factory and has a large following from riders and pet owners across the world. Please follow the link to the website – www.theherbalhorse.co.uk to see all the amazing blogs and the ability to purchase these products online. The Equine and Pet Range were introduced to the UK Market in September 2014 by Raman Pharma to give the UK a taste of the future in equine and companion animal nutritional supplements.
Update (20/02/2020): resupply dates now expected: Famotidine 20mg tablets are out of stock until the end of February 2020 (Tilomed) Mid March 2020 (Teva) Cimetidine 200mg tablets are out of stock until the end of March 2020 (Ennogen) May 2020 (Medley Pharma) Nizatidine 150mg and 300mg tablets: No confirmed resupply date (Medreich and Mylan) Department...
Update (20/02/2020): resupply date now expected mid April 2020 for the 500mg suppositories, mid September 2020 for the 1g suppositories First published 24th October 2019 Dr Falk the sole supplier of the 500mg mesalazine suppository (Salofalk suppositories 500mg) has announced that they expect to be out of stock of this line until mid-December 2019. The...
Update (20/02/2020): resupply date now expected early March 2020 First published 25th October 2019 The Department of Health and Social Care (DHSC) have advised that paroxetine 20mg/10ml oral solution will be out of stock until January 2020 due to manufacturing delays. Paroxetine tablets remain available from various suppliers. Action required: For patients who do not...
Update (20/02/2020): resupply date now expected March 2020 First published 23rd August 2019 Pfizer, the sole supplier of Sayana Press (medroxyprogesterone acetate 104mg) in the UK, have informed the Department of Health and Social Care that due to manufacturing delays, Sayana Press will be out of stock until at least the end of 2019. Depo-Provera (medroxyprogesterone...
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Lorazepam (Ativan®) 4mg/ml injection (Pfizer). Pfizer have limited supplies of Lorazepam (Ativan®) 4mg/ml injection and anticipate going out of stock by 6th March 2020. The anticipated re-supply date is w/c 16th March 2020 The DHSC Medicine Supply Team provide a monthly...
Update (20/02/2020): resupply date now expected end of March 2020 GlaxoSmithKline (GSK) and Pinewood, the manufacturers of Salbutamol 2mg/5ml syrup, are currently experiencing temporary disruptions. GSK, the main supplier of Salbutamol 2mg/5ml syrup (Ventolin) have advised a resupply date of early August 2019 Pinewood are long term out of stock due to manufacturing issues and are...
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Penicillamine 125mg and 250mg tablets. Penicillamine 125mg tablets are out of stock until late March 2020. Penicillamine 250mg tablets are out of stock, with an anticipated re-supply date end of February 2020. Further information can be found on the Specialist Pharmacy...
Drug alert number: EL (20)A/10 Date issued: 20 February 2020 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 pharmacy level caution in use for: Crescent Pharma Ltd, Flamingo Pharma (Uk) Ltd, Ibuprofen 400mg Tablets (Various Liveries) Crescent Pharma Ltd and Flamingo Pharma (UK) Ltd have informed the MHRA that the...
The team at PSNC has received a number of queries on the Pharmacy Quality Scheme (PQS). Below are some of the questions asked in recent weeks. Q. How do I enter the details of my Primary Care Network Pharmacy Lead in the MYS PQS declaration? A. During completion of the PQS declaration, contractors will be...
Abbott have advised that the temporary supply problems with FreeStyle Libre sensors have been resolved. Abbott has issued the following statement on 19th February 2020. ‘Abbott is sorry for the temporary delays in fulfilling FreeStyle Libre sensor orders and the impact this has had on the users as well as the wider diabetes community. The...
A pharmacist was today sentenced to 28 months in prison at the Birmingham Crown Court following an investigation by the MHRA.
Crescent Pharma Ltd and Flamingo Pharma (UK) Ltd have informed us that the Patient Information Leaflet (PIL) within their packs for the above pharmacy (P) batches is incorrect.
An application for a flu vaccine by Sanofi Pasteur, designed to be effective in the over-65 age group, was quickly approved to become available for the 2019 to 2020 flu season.
How to license a medicine for sale in the UK and Europe, including applications through national, centralised and decentralised procedures.
Summary List of field safety notices (FSNs) from medical device manufacturers from 10 to 14 February 2020
Accord Healthcare Ltd has informed us of an issue related to the expiry date for the above batches, which has not been encoded in 2D data matrix.
The Medicines and Healthcare products Regulatory Agency (MHRA) launches a week long social media campaign to raise awareness about the importance of reporting suspected side effects using the Yellow Card Scheme.
Marketing authorisations granted in January 2020
Parallel import licenses granted in January 2020
Public list of companies in the UK who have had their licence/registration to manufacture or wholesale medicines/ingredients revoked or suspended.
Manufactured by Cordis – instructions for use contain incorrect MRI compatibility information.
Accord-UK Limited is recalling all unexpired stock of Gliclazide 40 mg Tablets (Northstar Livery) from pharmacies and wholesalers as a precautionary measure due to out of specification results for dissolution, obtained during routine stability testing.
Monthly PDF editions of the Drug Safety Update newsletter from MHRA and its independent advisor the Commission on Human Medicines.
Stop prescribing Picato and consider other treatment options for actinic keratosis as appropriate. The licence of ingenol mebutate (Picato) has been suspended as a precautionary measure while the European Medicines Agency (EMA) continues to investigate concerns about a possible increased risk of skin malignancy.
A review of the benefits and risks of alemtuzumab (including fatal reactions) in the treatment of multiple sclerosis has now concluded and recommended a revised indication, additional contraindications, and strengthened monitoring requirements before, during and after treatment. Patients offered alemtuzumab should be alerted to the early risks of cardiovascular events and thrombocytopenia around the time of infusion and to the delayed risk of immune-mediated reactions. Healthcare professionals should inform patients what to do if they develop any symptoms of these disorders.
In January 2020, healthcare professionals received updated educational materials to support the valproate pregnancy prevention programme. Valproate is contraindicated in girls and women of childbearing potential, unless the conditions of the pregnancy prevention programme are met.
Amended advice on the insertion site for Nexplanon contraceptive implants following concerns regarding reports of neurovascular injury and implants migrating to the vasculature (including the pulmonary artery).
Be especially alert for adverse drug reactions (ADRs) in patients taking more than one medicine and report any suspected ADRs to the Yellow Card Scheme. Show your support for the MHRA’s ADR awareness week campaign on 17–23 February 2020 by sharing material on social media and discussing with colleagues and patients the importance of reporting suspected side effects.
Letters were sent about methotrexate, modafinil, Ecalta, Picato, Nexplanon, valproate medicines, e-cigarettes, and Lemtrada. Alerts were issued about finasteride, codeine/paracetamol, and Picato.
Alerts were issued about Convex two-piece skin barriers for use with ostomy bags and HeartStart XL+ defibrillators. A notice was also issued following reports of falsely depressed creatinine results for patients on phenindione therapy when using the enzymatic methodology of the ADVIA assay.
From 1 April emails sent to the VMD's old email address will no longer be re-directed to the current email address.
Summary of the annual review 2018 of veterinary pharmacovigilance in the UK.
A review of adverse events following the use of veterinary medicines reported in 2018
As a vet or pharmacist, you must follow legal requirements when working with controlled drugs in veterinary medicine.
Marketing Authorisation Holders (MAHs) have informed the VMD of supply problems with the following lactating cow intramammary antibiotics.
Animal medicines seizure notices: Published following the conclusion of an investigation case.
Reporting against VMD published standards up to 31 January 2020.
Marketing Authorisations Information Service (MAVIS) Hub edition 113
Details of seizure notice served to Gansera Leveque, Newmarket Published in February 2020
Application form for a licence to conduct a clinical trial using an animal medicine (animal test certificate).
Details of the improvement notice served to Companion Care, Orpington, Kent
Requirement to analyse samples from food producing animals for residues of veterinary medicines and prohibited substances.
Sets out legal text on the manufacture, authorisation, marketing, distribution and post-authorisation surveillance of veterinary medicines.
This is the hub for all the Veterinary Medicines Directorate's communications on the Transition Period.
For a marketing authorisation holder only; how to report a defect with a veterinary medicine.
Vetpol has been recognised to maintain register of SQPs to prescribe, supply and advise on the safe use of POM-VPS and NFA-VPS veterinary medicines.
Product defect recall alert for Clavubactin 50/12.5mg (Vm 19994/4028), Clavubactin 250/62.5mg (Vm 19994/4026), Clavubactin 500/125mg (Vm 19994/4027) by Le Vet Pharma
Residues of veterinary medicines in food 2019 surveillance results.
Data on the difference in employees’ average earnings from April 2018 to March 2019.
Details of seizure notice served to Guasco & Associates, Cheltenham. Published in January 2020
The test, which is used to detect kidney damage that can lead to fatal complications, should be conducted every year.
In a trial, the drug improved overall survival by 7.1 months compared with chemotherapy.
The designation was granted based on results from the dose-escalation cohort and expansion cohort A of the EV-103 Phase Ib/II trial.
The step marks a “pivotal milestone" for Versius.
There was a 34% increase in overdose deaths caused by propranolol between 2012 and 2017, and by 2016 nearly 4.7 million prescriptions were issued to patients annually.
Bristol-Meyers Squibb said that it will continue to support the evaluation of cabiralizumab in select, ongoing investigator-sponsored trials.
The decision was based on results from the Phase III ATTR-ACT study.
The company joins J&J, Gilead and GSK in the ranks searching for a vaccine for the global health epidemic.
Jake Ternet, patient at Moorfields Eye Hospital was the first in the UK to receive the treatment.
The Society hopes that the new online function will relieve pressure on healthcare professionals, and could result in significant cost savings for the NHS as demand for the face-to-face programme lessens.
Understanding how cells communicate could reveal how tumours are able to evade the immune system and become resistant to treatments.
To develop the maps, the team looked within 483 different tumour samples for the presence of 37 key proteins.
The drug is the first EC-approved anti-VEGF treatment to demonstrate superior resolution of retinal fluid, compared to Bayer's Eylea.
The news comes as drug discovery rates are declining, the price of bringing a drug to market is increasing, and return on investment (ROI) on R&D is expected to hit 0% in the next few years.
Macmillan Cancer Support has cited “soaring” pressures on the NHS, leaving staff table to provide the appropriate care for patients.
Unit 2 Fleet Business Park, Sandy Lane, Church Crookham, Fleet, Hampshire, GU52 8BF
Pharmaceutical and Veterinary Licensed Distributor. WDA (H) 43703 & WDA (V) 43703.
- +44 (0)1252 260 460.
- +44 (0)1276 469 290
Monday to Friday - 09:30 – 18:30
Saturday & Sunday - Closed, Online Ordering Available